{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:19:28Z","timestamp":1759483168566},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4723,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1046\/j.1523-1755.2003.00700.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T09:52:16Z","timestamp":1047462736000},"page":"1-11","source":"Crossref","is-referenced-by-count":44,"title":["Parathyroid hormone (PTH), PTH-derived peptides, and new PTH assays in renal osteodystrophy"],"prefix":"10.1016","volume":"63","author":[{"given":"William G.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald J.","family":"Sherrard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure: An evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0015","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.2001.0590031187.x","article-title":"Recent developments in the management of secondary hyperparathyroidism","volume":"59","author":"Goodman","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ki.1995.335","article-title":"Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy","volume":"48","author":"Salusky","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1681\/ASN.V9154","article-title":"1,25(OH)2-vitamin D3 reduces spontaneous and hypocalcemic-stimulated pulsatile component of parathyroid hormone secretion","volume":"9","author":"Schmitt","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0030","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0272-6386(95)90453-0","article-title":"Relationship between intact 1-84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity","volume":"26","author":"Wang","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ki.1993.323","article-title":"Aplastic osteodystrophy without aluminum: The role of \u201csuppressed\u201d parathyroid function","volume":"44","author":"Hercz","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1056\/NEJM198908033210502","article-title":"Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure","volume":"321","author":"Andress","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0045","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/0272-6386(95)90599-5","article-title":"Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis","volume":"26","author":"Qi","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0055","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1993.226","article-title":"Renal osteodystrophy in diabetic patients","volume":"44","author":"Pei","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0060","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/ki.1992.202","article-title":"Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients","volume":"41","author":"Pei","year":"1992","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.1988.96","article-title":"Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD","volume":"33","author":"Salusky","year":"1988","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0070","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1681\/ASN.V3121938","article-title":"Renal bone disease in pediatric patients and young adults treated by hemodialysis in a childrens hospital","volume":"12","author":"Mathias","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0075","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ki.1993.350","article-title":"Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease","volume":"44","author":"Hutchison","year":"1993","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000420140","article-title":"Oral and parenteral calcitriol for the management of end-stage renal disease","volume":"90","author":"Coburn","year":"1991","journal-title":"Contrib Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0085","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.V981427","article-title":"19-Nor-1-\u03b1-25-dihydroxyvitamin D2 (paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis","volume":"9","author":"Martin","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0090","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/ajkd.2000.16193","article-title":"Intermittent doxercalciferol (1\u03b1-hydroxyvitamin D2) therapy for secondary hyperparathyroidism","volume":"36","author":"Frazao","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0095","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00041552-199411000-00009","article-title":"Calcitriol pulse therapy in patients with end-stage renal failure","volume":"3","author":"Monier-Faugere","year":"1994","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0100","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/ki.1995.201","article-title":"Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH","volume":"47","author":"Torres","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0105","first-page":"3923","article-title":"Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: Importance in the interpretation of PTH values","volume":"81","author":"Brossard","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0110","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/44.4.805","article-title":"A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples","volume":"44","author":"Lepage","year":"1998","journal-title":"Clin Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0115","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: Implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: Implications for improvement of accurate assessment of parathyroid function","volume":"16","author":"Gao","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0125","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2001.00949.x","article-title":"Improved assessment of bone turnover by the PTH-(1-84)\/large C-PTH fragments ratio in ESRD patients","volume":"60","author":"Monier-Faugere","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0130","first-page":"641","article-title":"Structure and expression of the human parathyroid hormone gene","volume":"42","author":"Kronenberg","year":"1986","journal-title":"Recent Prog Horm Res"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0135","first-page":"969","article-title":"Parathyroid hormone, and parathyroid hormone-related peptide in the regulation of calcium homeostasis and bone development (chapt 70)","volume":"vol 2","author":"J\u00fcppner","year":"2001"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0140","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0145","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1210\/endo.134.2.8299582","article-title":"The extracellular amino-terminal region of the parathyroid hormone (PTH)\/PTH-related peptide receptor determines the binding affinity for carboxyl-terminal fragments of PTH-(1-34)","volume":"134","author":"J\u00fcppner","year":"1994","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0150","series-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","first-page":"88","article-title":"Parathyroid hormone-related protein (chapt 69)","author":"Strewler","year":"1999"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0155","doi-asserted-by":"crossref","first-page":"28650","DOI":"10.1074\/jbc.M100717200","article-title":"Multiple sites of contact between the carboxyl-terminal binding domain of PTHrP(1-36) analogs and the amino-terminal extracellular domain of the PTH\/PTHrP receptor identified by photoaffinity crosslinking","volume":"276","author":"Gensure","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0160","doi-asserted-by":"crossref","first-page":"42692","DOI":"10.1074\/jbc.M106215200","article-title":"Identification of determinants of inverse agonism in a constitutively active parathyroid hormone\/parathyroid hormone-related peptide receptor by photoaffinity cross-linking and mutational analysis","volume":"276","author":"Gensure","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0165","doi-asserted-by":"crossref","first-page":"15455","DOI":"10.1074\/jbc.270.26.15455","article-title":"Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor","volume":"270","author":"Usdin","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0170","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1210\/endo.140.10.7040","article-title":"Comparison of rat and human parathyroid hormone 2 (PTH2) receptor activation: PTH is a low potency partial agonist at the rat PTH2 receptor","volume":"140","author":"Hoare","year":"1999","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0175","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/endo.137.7.8770894","article-title":"The human PTH2 receptor: Binding and signal transduction properties of the stably expressed recombinant receptor","volume":"137","author":"Behar","year":"1996","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0180","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/14724","article-title":"TIP39: A new neuropeptide and PTH2-receptor agonist from hypothalamus","volume":"2","author":"Usdin","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0185","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1210\/endo.143.3.8698","article-title":"Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues","volume":"143","author":"John","year":"2002","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0190","first-page":"761","article-title":"Tuberoinfundibular peptide (7-39) [TIP(7-39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with no detectable agonist activity","volume":"295","author":"Hoare","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0195","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1210\/endo.142.2.7945","article-title":"Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)\/PTH-related peptide receptor, but functions as an antagonist","volume":"142","author":"Jonsson","year":"2001","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0200","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.042416199","article-title":"Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception","volume":"99","author":"Dobolyi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0205","doi-asserted-by":"crossref","first-page":"28185","DOI":"10.1074\/jbc.274.40.28185","article-title":"Zebrafish express the common parathyroid hormone\/parathyroid hormone-related peptide receptor (PTH1R) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide","volume":"274","author":"Rubin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0210","doi-asserted-by":"crossref","first-page":"23035","DOI":"10.1074\/jbc.274.33.23035","article-title":"A G protein-coupled receptor from zebrafish is activated by human parathyroid hormone and not by human or teleost parathyroid hormone-related peptide. Implications for the evolutionary conservation of calcium-regulating peptide hormones","volume":"274","author":"Rubin","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0215","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1210\/endo.141.9.7645","article-title":"Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors: comparison of PTH, PTH-related protein, and tuberoinfundibular peptide of 39 residues","volume":"141","author":"Hoare","year":"2000","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0220","first-page":"E437","article-title":"Comparison of renal and osseous binding of parathyroid hormone and hormonal fragments","volume":"249","author":"Demay","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0225","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1210\/endo-117-4-1632","article-title":"Binding of intact parathyroid hormone to rat osteosarcoma cells: Major contribution of binding sites for the carboxyl-terminal region of the hormone","volume":"117","author":"Rao","year":"1985","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0230","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/endo-117-5-1930","article-title":"Binding of intact parathyroid hormone to chicken renal membranes: Evidence for a second binding site with carboxyl-terminal specificity","volume":"117","author":"McKee","year":"1985","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0235","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02565133","article-title":"Dexamethasone-treated ROS 17\/2.8 rat osteosarcoma cells are responsive to human carboxylterminal parathyroid hormone peptide hPTH(53-84): Stimulation of alkaline phosphatase","volume":"49","author":"Murray","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0240","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1210\/endo.136.11.7588200","article-title":"Characterization of a novel PTH-receptor with specificity for the carboxyl-terminal region of PTH(1-84)","volume":"136","author":"Inomata","year":"1995","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0245","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1210\/endo.142.4.8093","article-title":"Synthetic carboxyl-terminal fragments of parathyroid hormone (PTH) decrease ionized calcium concentration in rats by acting on a receptor different from the PTH\/PTH-related peptide receptor","volume":"142","author":"Nguyen-Yamamoto","year":"2001","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0250","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0085-2538(15)47156-X","article-title":"A novel mechanism for skeletal resistance in uremia","volume":"58","author":"Slatopolsky","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/endo.143.1.8575","article-title":"Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH\/PTHrP receptor","volume":"143","author":"Divieti","year":"2002","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0260","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0265","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1210\/endo.142.2.7955","article-title":"Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells","volume":"142","author":"Divieti","year":"2001","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0270","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1152\/physrev.1984.64.3.985","article-title":"Parathyroid hormone: Biochemical aspects of biosynthesis, secretion, action, and metabolism","volume":"64","author":"Habener","year":"1984","journal-title":"Physiol Rev"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0275","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1210\/endo-104-6-1778","article-title":"Effects of plasma calcium concentration on the relative proportion of hormone and carboxyl fragments in parathyroid venous blood","volume":"104","author":"Mayer","year":"1979","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0280","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI110052","article-title":"Effects of hepatectomy, nephrectomy, and nephrectomy\/uremia on the metabolism of parathyroid hormone in the rat","volume":"67","author":"Segre","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0285","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/jbmr.5650110806","article-title":"Influence of Ca2+ concentration on the clearance and circulating levels of intact and carboxy-terminal iPTH in pentobarbital-anesthetized dogs","volume":"11","author":"D'Amour","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJM199507273330407","article-title":"Calcium-ion\u2013sensing cell-surface receptors","volume":"333","author":"Brown","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0295","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.82.12.4270","article-title":"Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells","volume":"82","author":"Silver","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0300","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0021-9258(18)69191-4","article-title":"5\u2032-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3","volume":"263","author":"Okazaki","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0305","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of bovine and human parathyroid hormone","volume":"49","author":"Berson","year":"1963","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0310","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1210\/jcem-28-7-1037","article-title":"Immunochemical heterogeneity of parathyroid hormone in plasma","volume":"28","author":"Berson","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0315","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM197801052980107","article-title":"Impaired parathyroid hormone metabolism in patients with chronic renal failure","volume":"298","author":"Freitag","year":"1978","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0320","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1074\/jbc.274.9.5620","article-title":"Megalin antagonizes activation of the parathyroid hormone receptor","volume":"274","author":"Hilpert","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0325","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/jcem-63-5-1163","article-title":"Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy","volume":"63","author":"Andress","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0330","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0335","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ki.1994.31","article-title":"Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD\/CCPD","volume":"45","author":"Salusky","year":"1994","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0340","first-page":"145","article-title":"Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia","volume":"75","author":"Quarles","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0345","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/jcem-73-3-516","article-title":"Comparison of intact, midregion, and carboxy-terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients","volume":"73","author":"Cohen-Solal","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0350","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199102213240804","article-title":"Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease","volume":"324","author":"Salusky","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0355","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1523-1755.1998.00045.x","article-title":"Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral and intraperitoneal administration","volume":"54","author":"Salusky","year":"1998","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0360","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ki.1996.287","article-title":"Coordinate regulation of PTH\/PTHrP receptors by PTH and calcitriol in UMR 106\u201301 osteoblast-like cells","volume":"50","author":"Gonzalez","year":"1996","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0365","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.2001.01139.x","article-title":"Histomorphometric assessment of bone turnover in uraemic patients: Comparison between activation frequency and bone formation rate","volume":"38","author":"Ballanti","year":"2001","journal-title":"Histopathology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0370","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0375","first-page":"221","article-title":"Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy","volume":"17","author":"Goodman","year":"1991","journal-title":"Miner Electrolyte Metab"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0380","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.5650100104","article-title":"Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids","volume":"10","author":"Sanchez","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0385","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM197601292940502","article-title":"Effects of diabetes mellitus on bone mass in juvenile and adult onset diabetes","volume":"294","author":"Levin","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0390","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1210\/endo-108-6-2228","article-title":"Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy","volume":"108","author":"Hough","year":"1981","journal-title":"Endocrinology"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0395","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2337\/diab.33.9.825","article-title":"Diminished bone formation in experimental diabetes: Relationship to osteoid maturation and mineralization","volume":"33","author":"Goodman","year":"1984","journal-title":"Diabetes"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0400","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1053\/ajkd.2002.34519","article-title":"PTH 1-84 and PTH \u201c7-84\u201d in the noninvasive diagnosis of renal bone disease","volume":"40","author":"Coen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2003.00700.x_bb0405","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/ndt\/11.6.1065","article-title":"Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in hemodialysis patients","volume":"11","author":"Couttenye","year":"1996","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815488398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815488398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T04:41:03Z","timestamp":1622868063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815488398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0085253815488398"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00700.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}